• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于标准化相对生存率。

On standardized relative survival.

作者信息

Sasieni Peter, Brentnall Adam R

机构信息

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, U.K.

出版信息

Biometrics. 2017 Jun;73(2):473-482. doi: 10.1111/biom.12578. Epub 2016 Aug 23.

DOI:10.1111/biom.12578
PMID:27554303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5507182/
Abstract

Cancer survival comparisons between cohorts are often assessed by estimates of relative or net survival. These measure the difference in mortality between those diagnosed with the disease and the general population. For such comparisons methods are needed to standardize cohort structure (including age at diagnosis) and all-cause mortality rates in the general population. Standardized non-parametric relative survival measures are evaluated by determining how well they (i) ensure the correct rank ordering, (ii) allow for differences in covariate distributions, and (iii) possess robustness and maximal estimation precision. Two relative survival families that subsume the Ederer-I, Ederer-II, and Pohar-Perme statistics are assessed. The aforementioned statistics do not meet our criteria, and are not invariant under a change of covariate distribution. Existing methods for standardization of these statistics are either not invariant to changes in the general population mortality or are not robust. Standardized statistics and estimators are developed to address the deficiencies. They use a reference distribution for covariates such as age, and a reference population mortality survival distribution that is recommended to approach zero with increasing age as fast as the cohort with the worst life expectancy. Estimators are compared using a breast-cancer survival example and computer simulation. The proposals are invariant and robust, and out-perform current methods to standardize the Ederer-II and Pohar-Perme estimators in simulations, particularly for extended follow-up.

摘要

不同队列之间的癌症生存率比较通常通过相对生存或净生存估计来评估。这些方法衡量了患该疾病者与一般人群之间的死亡率差异。对于此类比较,需要采用方法来标准化队列结构(包括诊断时的年龄)以及一般人群的全因死亡率。通过确定标准化非参数相对生存指标在以下方面的表现来对其进行评估:(i)确保正确的排名顺序;(ii)考虑协变量分布的差异;(iii)具备稳健性和最大估计精度。对包含埃德勒-I、埃德勒-II和波哈尔-佩尔梅统计量的两个相对生存族进行了评估。上述统计量不符合我们的标准,并且在协变量分布变化时不具有不变性。现有的这些统计量标准化方法要么对一般人群死亡率的变化不具有不变性,要么不稳健。为解决这些缺陷,开发了标准化统计量和估计量。它们使用年龄等协变量的参考分布,以及一个参考人群死亡率生存分布,建议该分布随着年龄增长以与预期寿命最差的队列相同的速度趋近于零。使用乳腺癌生存实例和计算机模拟对估计量进行了比较。所提出的方法具有不变性和稳健性,并且在模拟中优于当前用于标准化埃德勒-II和波哈尔-佩尔梅估计量的方法,尤其是在长期随访中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/8c43d67bdd90/BIOM-73-473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/738d8e7f1edf/BIOM-73-473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/3172554b2fa1/BIOM-73-473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/8c43d67bdd90/BIOM-73-473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/738d8e7f1edf/BIOM-73-473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/3172554b2fa1/BIOM-73-473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9330/5507182/8c43d67bdd90/BIOM-73-473-g003.jpg

相似文献

1
On standardized relative survival.关于标准化相对生存率。
Biometrics. 2017 Jun;73(2):473-482. doi: 10.1111/biom.12578. Epub 2016 Aug 23.
2
Comparing net survival estimators of cancer patients.比较癌症患者的净生存估计值。
Stat Med. 2016 May 20;35(11):1866-79. doi: 10.1002/sim.6833. Epub 2015 Dec 28.
3
Comparison of different approaches to estimating age standardized net survival.不同年龄标准化净生存估计方法的比较。
BMC Med Res Methodol. 2015 Aug 15;15:64. doi: 10.1186/s12874-015-0057-3.
4
Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.癌症登记数据的净生存:新无偏 Pohar-Perme 估计器的使用和经典方法的偏差幅度。
Int J Cancer. 2013 May 15;132(10):2359-69. doi: 10.1002/ijc.27830. Epub 2012 Oct 3.
5
Choosing the net survival method for cancer survival estimation.选择用于癌症生存估计的净生存方法。
Eur J Cancer. 2015 Jun;51(9):1123-9. doi: 10.1016/j.ejca.2013.09.019. Epub 2013 Oct 29.
6
Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.通过纳入时变权重,直接建立年龄标准化边际相对生存率模型。
BMC Med Res Methodol. 2021 Apr 24;21(1):84. doi: 10.1186/s12874-021-01266-1.
7
Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets.通过系统性地从风险人群中移除患者来实现病因特异性和相对生存率的公平比较。
Cancer Epidemiol. 2023 Oct;86:102408. doi: 10.1016/j.canep.2023.102408. Epub 2023 Aug 15.
8
Using pseudo-observations for estimation in relative survival.使用伪观测值进行相对生存率估计。
Biostatistics. 2019 Jul 1;20(3):384-399. doi: 10.1093/biostatistics/kxy008.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Estimating net survival: the importance of allowing for informative censoring.估计净生存率:允许信息性删失的重要性。
Stat Med. 2012 Apr 13;31(8):775-86. doi: 10.1002/sim.4464. Epub 2012 Jan 26.

引用本文的文献

1
Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern China.运用周期分析及时评估中国东部台州市乳腺癌患者的5年相对生存率。
Front Oncol. 2022 Dec 12;12:998641. doi: 10.3389/fonc.2022.998641. eCollection 2022.
2
Integrating relative survival in multi-state models-a non-parametric approach.将相对生存纳入多状态模型 - 一种非参数方法。
Stat Methods Med Res. 2022 Jun;31(6):997-1012. doi: 10.1177/09622802221074156. Epub 2022 Mar 14.
3
Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.

本文引用的文献

1
Comparison of different approaches to estimating age standardized net survival.不同年龄标准化净生存估计方法的比较。
BMC Med Res Methodol. 2015 Aug 15;15:64. doi: 10.1186/s12874-015-0057-3.
2
Informative censoring in relative survival.相对生存率中的信息性删失。
Stat Med. 2013 Nov 30;32(27):4791-802. doi: 10.1002/sim.5877. Epub 2013 Jun 12.
3
Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.癌症登记数据的净生存:新无偏 Pohar-Perme 估计器的使用和经典方法的偏差幅度。
非参数估计参考调整后、标准化的全因死亡率和癌症死亡率的概率,用于人群比较。
BMC Med Res Methodol. 2022 Jan 6;22(1):2. doi: 10.1186/s12874-021-01465-w.
4
Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.通过纳入时变权重,直接建立年龄标准化边际相对生存率模型。
BMC Med Res Methodol. 2021 Apr 24;21(1):84. doi: 10.1186/s12874-021-01266-1.
5
Risk Models for Breast Cancer and Their Validation.乳腺癌风险模型及其验证
Stat Sci. 2020 Mar 3;35(1):14-30. doi: 10.1214/19-STS729.
6
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.调和欧洲随机前列腺癌筛查研究(ERSPC)和前列腺、肺癌、结直肠癌和卵巢癌筛查试验(PLCO)中筛查对前列腺癌死亡率的影响。
Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.
7
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.BRAF 和 NRAS 突变在黑色素瘤中的预后意义:一项来自常规护理的德国研究。
BMC Cancer. 2017 Aug 10;17(1):536. doi: 10.1186/s12885-017-3529-5.
Int J Cancer. 2013 May 15;132(10):2359-69. doi: 10.1002/ijc.27830. Epub 2012 Oct 3.
4
On estimation in relative survival.关于相对生存的估计
Biometrics. 2012 Mar;68(1):113-20. doi: 10.1111/j.1541-0420.2011.01640.x. Epub 2011 Jun 20.
5
How to interpret the relative survival ratios of cancer patients.如何解读癌症患者的相对生存率。
Eur J Cancer. 2008 Nov;44(17):2661-7. doi: 10.1016/j.ejca.2008.08.016. Epub 2008 Sep 24.
6
Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.针对生存数据,采用治疗权重逆概率的调整后Kaplan-Meier估计器和对数秩检验。
Stat Med. 2005 Oct 30;24(20):3089-110. doi: 10.1002/sim.2174.
7
An alternative approach to age adjustment of cancer survival rates.一种调整癌症生存率年龄因素的替代方法。
Eur J Cancer. 2004 Oct;40(15):2317-22. doi: 10.1016/j.ejca.2004.07.007.
8
Standard cancer patient population for age standardising survival ratios.用于年龄标准化生存率的标准癌症患者群体。
Eur J Cancer. 2004 Oct;40(15):2307-16. doi: 10.1016/j.ejca.2004.07.002.
9
On crude and age-adjusted relative survival rates.关于粗生存率和年龄调整后的相对生存率。
J Clin Epidemiol. 2003 Dec;56(12):1185-91. doi: 10.1016/s0895-4356(03)00209-9.
10
The relative survival rate: a statistical methodology.相对生存率:一种统计方法。
Natl Cancer Inst Monogr. 1961 Sep;6:101-21.